Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Biohit Oyj - Managers' Transactions


Posted on: 05 Mar 18

Biohit Oyj - Managers' Transactions, March 5, 2018 at 2:00 pm local time (EEST)

Biohit Oyj has received the following notification.

Biohit Oyj - Managers' Transactions
____________________________________________

Person subject to the notification requirement
Name: Ilari Patrakka
Position: Other senior manager
Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29

Notification type: INITIAL NOTIFICATION
Reference number: 74370089ATTSNBXJVT29_20180301113245_5
____________________________________________

Transaction date: 2018-02-28
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009005482
Nature of the transaction: DISPOSAL

Transaction details
(1): Volume: 200 Unit price: 4.48 EUR
(2): Volume: 300 Unit price: 4.48 EUR
(3): Volume: 241 Unit price: 4.48 EUR
(4): Volume: 97 Unit price: 4.5 EUR
(5): Volume: 22 Unit price: 4.5 EUR
(6): Volume: 2,303 Unit price: 4.5 EUR
(7): Volume: 97 Unit price: 4.5 EUR
(8): Volume: 129 Unit price: 4.5 EUR
(9): Volume: 97 Unit price: 4.5 EUR
(10): Volume: 147 Unit price: 4.5 EUR
(11): Volume: 211 Unit price: 4.5 EUR
(12): Volume: 3 Unit price: 4.5 EUR
(13): Volume: 221 Unit price: 4.5 EUR
(14): Volume: 241 Unit price: 4.5 EUR
(15): Volume: 145 Unit price: 4.5 EUR
(16): Volume: 1,100 Unit price: 4.54 EUR
(17): Volume: 500 Unit price: 4.5 EUR
(18): Volume: 2,000 Unit price: 4.5 EUR
(19): Volume: 250 Unit price: 4.5 EUR
(20): Volume: 77 Unit price: 4.56 EUR
(21): Volume: 109 Unit price: 4.57 EUR
(22): Volume: 310 Unit price: 4.55 EUR
(23): Volume: 800 Unit price: 4.55 EUR

Aggregated transactions
(23): Volume: 9,600 Volume weighted average price: 4.5101 EUR

Additional information: 

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

GlobeNewswire
globenewswire.com

Last updated on: 05/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.